Inventor · disambiguated record
Julia Guy
Also filed as: GUY JULIA
6 granted patents·1 pending application·39 citations·filing 2013–2024
82Inventor score
Files withBRISTOL MYERS SQUIBB CO7
Top patents by PatentIndex Score
7 records- 0193US10047103B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 14, 2018·11 cites·22 claims
- 0292US10822343B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 3, 2020·4 cites·15 claims
- 0392US10428077B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 1, 2019·8 cites·9 claims
- 0490US9688695B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 27, 2017·11 cites·51 claims
- 0586US9862730B2Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 9, 2018·5 cites·11 claims
- 0685US2025002497A1Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0780US12084452B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 10, 2024·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →